Last reviewed · How we verify

NCT05646654

Interscalene Block Versus Erector Spinae Plane Block for Shoulder Arthroscopy Anesthesia

Status unknown NA Last updated 19 April 2023
What this trial tests

NA trial testing Erector spinae plane block in Interscalene Block in 54 participants. Status unknown.

Timeline
15 December 2022
Primary endpoint
15 May 2023
15 May 2023

Quick facts

Lead sponsorTanta University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeother
Enrollment54
Start date15 December 2022
Primary completion15 May 2023
Estimated completion15 May 2023
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Tanta University

Who can join

Adults 18 to 65, any sex, with Interscalene Block or Erector Spinae Plane Block. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to compare the effectiveness of ESPB versus ISB in anesthesia for shoulder arthroscopy

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Erector spinae plane block

Trials testing the same drug.

Other recruiting trials for Interscalene Block

Currently open trials in the same condition.

Other Tanta University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05646654.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing